Pila Pharma AB Ratios and Metrics

Market cap in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Jan '26 Jan 21, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Market Capitalization	90	102	38	50	109	-	Upgrade
Market Cap Growth	-11.88%	167.21%	-23.60%	-54.48%	-	-	Upgrade
Enterprise Value	89	99	38	45	77	-	Upgrade
Last Close Price	2.13	3.75	1.60	3.10	6.64	-	Upgrade
PS Ratio	93.58	128.78	26.02	26.50	152.22	-	Upgrade
PB Ratio	77.34	19.33	5.72	5.23	3.61	-	Upgrade
P/TBV Ratio	144.58	24.31	8.45	7.91	4.05	-	Upgrade
EV/Sales Ratio	92.45	125.56	26.26	23.77	106.59	-	Upgrade
Debt / Equity Ratio	-	-	-	-	-	0.15	Upgrade
Asset Turnover	0.24	0.11	0.15	0.09	0.04	-	Upgrade
Quick Ratio	0.53	5.16	3.47	5.49	18.72	1.00	Upgrade
Current Ratio	0.95	5.21	3.48	5.59	18.81	1.05	Upgrade
Return on Equity (ROE)	-602.96%	-188.57%	-122.66%	-134.47%	-102.07%	-128.36%	Upgrade
Return on Assets (ROA)	-127.45%	-69.05%	-41.32%	-26.03%	-31.14%	-31.74%	Upgrade
Return on Invested Capital (ROIC)	-271.76%	-85.02%	-49.36%	-27.90%	-33.83%	-37.13%	Upgrade
Return on Capital Employed (ROCE)	-700.40%	-154.10%	-96.00%	-93.30%	-30.60%	-98.80%	Upgrade
Earnings Yield	-12.56%	-11.05%	-26.08%	-53.74%	-15.72%	-	Upgrade
Buyback Yield / Dilution	-14.01%	-20.66%	-22.29%	-31.86%	-30.89%	-	Upgrade

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.